Immune Response Induced by Standard and Fractional Doses of 17DD Yellow Fever Vaccine

The re-emergence of yellow fever (YF) urged new mass vaccination campaigns and, in 2017, the World Health Organization approved the use of the fractional dose (FD) of the YF vaccine due to stock shortage. In an observational cross-sectional investigation, we have assessed viremia, antibodies, soluble mediators and effector and memory T and B-cells induced by primary vaccination of volunteers with FD and standard dose (SD). Similar viremia and levels of antibodies and soluble markers were induced early after immunization. However, a faster decrease in the latter was observed after SD. The FD led to a sustained expansion of helper T-cells and an increased expression of activation markers on T-cells early after vaccination. Although with different kinetics, expansion of plasma cells was induced upon SD and FD immunization. Integrative analysis reveals that FD induces a more complex network involving follicular helper T cells and B-cells than SD. Our findings substantiate that FD can replace SD inducing robust correlates of protective immune response against YF.

References

Ahmed R, Pulendran B . Learning vaccinology from viral infections. J Exp Med. 2011; 208(12):2347-9. PMC: 3256975. DOI: 10.1084/jem.20112321. View

Theiler M, Smith H . THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION. J Exp Med. 2009; 65(6):787-800. PMC: 2133527. DOI: 10.1084/jem.65.6.787. View

Campi-Azevedo A, Costa-Pereira C, Antonelli L, Fonseca C, Teixeira-Carvalho A, Villela-Rezende G . Booster dose after 10 years is recommended following 17DD-YF primary vaccination. Hum Vaccin Immunother. 2015; 12(2):491-502. PMC: 5049740. DOI: 10.1080/21645515.2015.1082693. View

Fontana Sutile Tardetti Fantinato F, Wachira V, Porto V, Peixoto H, Duarte E . Factors associated with yellow fever vaccine failure: A systematic literature review. Vaccine. 2023; 41(13):2155-2169. DOI: 10.1016/j.vaccine.2023.02.007. View

Annunziato F, Cosmi L, Santarlasci V, Maggi L, Liotta F, Mazzinghi B . Phenotypic and functional features of human Th17 cells. J Exp Med. 2007; 204(8):1849-61. PMC: 2118657. DOI: 10.1084/jem.20070663. View

Koopman G, Mooij P, Dekking L, Mortier D, Nieuwenhuis I, van Heteren M . Correlation between Virus Replication and Antibody Responses in Macaques following Infection with Pandemic Influenza A Virus. J Virol. 2015; 90(2):1023-33. PMC: 4702706. DOI: 10.1128/JVI.02757-15. View

Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M . Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med. 2000; 192(11):1545-52. PMC: 2193094. DOI: 10.1084/jem.192.11.1545. View

Martins R, Maia M, Farias R, Camacho L, Freire M, Galler R . 17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother. 2013; 9(4):879-88. PMC: 3903908. DOI: 10.4161/hv.22982. View

Campi-Azevedo A, de Almeida Estevam P, Coelho-Dos-Reis J, Peruhype-Magalhaes V, Villela-Rezende G, Quaresma P . Subdoses of 17DD yellow fever vaccine elicit equivalent virological/immunological kinetics timeline. BMC Infect Dis. 2014; 14:391. PMC: 4223624. DOI: 10.1186/1471-2334-14-391. View

10.

Campi-Azevedo A, de Araujo-Porto L, Luiza-Silva M, Batista M, Martins M, Sathler-Avelar R . 17DD and 17D-213/77 yellow fever substrains trigger a balanced cytokine profile in primary vaccinated children. PLoS One. 2012; 7(12):e49828. PMC: 3519464. DOI: 10.1371/journal.pone.0049828. View

11.

Campi-Azevedo A, Reis L, Peruhype-Magalhaes V, Coelho-Dos-Reis J, Antonelli L, Fonseca C . Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children. Front Immunol. 2019; 10:2192. PMC: 6775283. DOI: 10.3389/fimmu.2019.02192. View

12.

Kohler S, Bethke N, Bothe M, Sommerick S, Frentsch M, Romagnani C . The early cellular signatures of protective immunity induced by live viral vaccination. Eur J Immunol. 2012; 42(9):2363-73. DOI: 10.1002/eji.201142306. View

13.

de Melo A, da Silva M, Magalhaes M, Gil L, Freese de Carvalho E, Braga-Neto U . Description of a prospective 17DD yellow fever vaccine cohort in Recife, Brazil. Am J Trop Med Hyg. 2011; 85(4):739-47. PMC: 3183786. DOI: 10.4269/ajtmh.2011.10-0496. View

14.

Gaucher D, Therrien R, Kettaf N, Angermann B, Boucher G, Filali-Mouhim A . Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses. J Exp Med. 2008; 205(13):3119-31. PMC: 2605227. DOI: 10.1084/jem.20082292. View

15.

Morita R, Schmitt N, Bentebibel S, Ranganathan R, Bourdery L, Zurawski G . Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011; 34(1):108-21. PMC: 3046815. DOI: 10.1016/j.immuni.2010.12.012. View

16.

Bonecchi R, Bianchi G, Bordignon P, DAmbrosio D, Lang R, Borsatti A . Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998; 187(1):129-34. PMC: 2199181. DOI: 10.1084/jem.187.1.129. View

17.

Romano M, Sironi M, Toniatti C, Polentarutti N, Fruscella P, Ghezzi P . Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment. Immunity. 1997; 6(3):315-25. DOI: 10.1016/s1074-7613(00)80334-9. View

18.

Fuller K, Kanagawa O, Nahm M . T cells within germinal centers are specific for the immunizing antigen. J Immunol. 1993; 151(9):4505-12. View

19.

Lacotte S, Brun S, Muller S, Dumortier H . CXCR3, inflammation, and autoimmune diseases. Ann N Y Acad Sci. 2009; 1173:310-7. DOI: 10.1111/j.1749-6632.2009.04813.x. View

20.

Rabin R, Alston M, Sircus J, Knollmann-Ritschel B, Moratz C, Ngo D . CXCR3 is induced early on the pathway of CD4+ T cell differentiation and bridges central and peripheral functions. J Immunol. 2003; 171(6):2812-24. DOI: 10.4049/jimmunol.171.6.2812. View